The company has said in regulatory filings that investigations, audits and reviews by a dozen different government agencies ...

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic ...

UnitedHealth's challenges are manageable, leadership changes boost confidence, and long-term growth shows promise with 15% ...

Deutsche Bank analyst George Hill joins ‘Closing Bell Overtime’ to discuss why he maintains his buy ratings on UnitedHealth ...

UnitedHealth shares jumped Friday after tumbling to pandemic-era lows on Thursday following reports that the company is being ...

UnitedHealth Group faces real PBM reform risks, but legal paths, financials, and market pricing suggest opportunity in ...

UnitedHealth stock was climbing on Friday. It's one of the Dow's 30 constituents, so the rebound is good news for the ...

We're witnessing one of the most dramatic declines by major, well-capitalized stocks in recent memory. Health insurance giant ...

UnitedHealth stock is rising after declining for eight consecutive sessions, Applied Materials issues a disappointing revenue ...

The U.S. Department of Justice is carrying out a criminal investigation into UnitedHealth Group for possible Medicare fraud, ...

The company’s stock has declined over its financial performance and the sudden replacement of its CEO.

UnitedHealth Group CEO Andrew Witty is stepping down from his post for personal reasons and the healthcare giant says it’s ...